Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort
The American Journal of Clinical Nutrition · 2023-12 · 118 (6) · 1224-1234
DOI: 10.1016/j.ajcnut.2023.09.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Clinical Nutrition, 2023-12. Verfasst von Kamil Demircan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Endocrinology, Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité-Universitätsmedizin Berlin, Freie Un…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Insulin Resistance, Selenium. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Diet is an important modifiable risk factor for gestational diabetes mellitus (GDM) and its related complications; however, the role of essential micronutrients such as selenium (Se), particularly in populations with low Se intake, is inconclusive. OBJECTIVES: The aim was to investigate the association of 3 established biomarkers of Se status with GDM, gestational glucose metabolism, and large for gestational-age offspring. METHODS: This study included 1346 pregnant females with 2294 serum samples from the prospective, population-based Odense Child Cohort study, Denmark. Serum Se, selenoprotein P (SELENOP) concentrations, and glutathione peroxidase 3 (GPX3) activity were measured in early and late pregnancy, and fasting glucose and insulin assessments in late pregnancy. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was calculated, and the GDM definition was according to the WHO 2013 threshold of fasting venous plasma glucose of ≥5.1 mmol/L. A subcohort underwent an oral glucose tolerance test. Regression models adjusted for various confounders quantified dose-dependent associations. RESULTS: Se and SELENOP declined during pregnancy. There were dose-dependent inverse associations of early GPX3 with late pregnancy GDM (WHO 2013), fasting glucose, insulin, HOMA-IR, and 2 h glucose. The odds ratio (OR) of GDM was 0.33 (95% CI: 0.16, 0.65) for 1 log-scale-increment in early GPX3 activity. Late pregnancy GPX3 and SELENOP were inversely associated with GDM and HOMA-IR; the OR of GDM was 0.21 (95% CI: 0.12, 0.38) and 0.52 (95% CI: 0.35, 0.77), for 1 log-scale-increment of GPX3 and SELENOP, respectively. A decline in Se biomarkers during pregnancy was associated with a higher risk of GDM and higher HOMA-IR. Low GPX3 activity in late pregnancy was associated with a higher risk of large for gestational-age offspring, partly (∼20%) mediated by fasting glucose concentrations (P = 0.006). CONCLUSIONS: Low serum Se in pregnancy, particularly GPX3 activity, is independently associated with risk of GDM and large for gestational age. Offering Se status assessment in pregnancy identifies females at high risk for GDM who may benefit from Se substitution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Experimental Endocrinology, Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute…
- Department of Endocrinology, Odense University Hospital, Kløvervænget, Odense C, and University of Southern Denmark, Odense, Denmark; Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, University…
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, J.B. Winsløws Vej, Odense C, Denmark; Odense Child Cohort, Hans Christian Andersen Children's Hospital, Odense Un…
- Department of Endocrinology, Odense University Hospital, Kløvervænget, Odense C, and University of Southern Denmark, Odense, Denmark.
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands; Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Demircan, K., Jensen, R. C., Chillon, T. S., Jensen, T. K., Sun, Q., Bonnema, S. J., Hackler, J., Korevaar, T. I. M., Glintborg, D., Schomburg, L., & Andersen, M. S. (2023). Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort. The American Journal of Clinical Nutrition, 118(6), 1224-1234. https://doi.org/10.1016/j.ajcnut.2023.09.025
Vancouver
Demircan K, Jensen RC, Chillon TS, Jensen TK, Sun Q, Bonnema SJ, et al. Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort. The American Journal of Clinical Nutrition. 2023;118(6):1224-1234. doi:10.1016/j.ajcnut.2023.09.025
BibTeX
@article{Demircan2023,
author = {Demircan, Kamil and Jensen, Richard Christian and Chillon, Thilo Samson and Jensen, Tina Kold and Sun, Qian and Bonnema, Steen Joop and Hackler, Julian and Korevaar, Tim I M and Glintborg, Dorte and Schomburg, Lutz and Andersen, Marianne Skovsager},
title = {Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort},
journal = {The American Journal of Clinical Nutrition},
year = {2023},
volume = {118},
number = {6},
pages = {1224--1234},
doi = {10.1016/j.ajcnut.2023.09.025}
}
EUVIMED